Drugs / GVAX Pancreas Vaccine (GVAX)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03153410 | Sep 2018 → Mar 2022 | malignant pancreatic neoplasm | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GVAX Pancreas Vaccine (GVAX) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03153410 ↗ |
| Modality | Vaccine | “GM-CSF-secreting allogenic pancreatic tumor cell vaccine (GVAX)” PMID 41878443 ↗ Mar 2026 |